Refine
Document Type
- Article (9)
- Doctoral Thesis (1)
Language
- English (10)
Has Fulltext
- yes (10)
Is part of the Bibliography
- no (10)
Keywords
- Cognition (1)
- Exotics (1)
- Hippocampal excitability (1)
- IntelliCage (1)
- Long-term potentiation (1)
- Lysophosphatidic acids (1)
- Particle and Resonance Production (1)
- Quarkonium (1)
- Spectroscopy (1)
- Touchscreen (1)
Institute
- Medizin (4)
- Biowissenschaften (2)
- Geowissenschaften (2)
- Physik (1)
- Psychologie und Sportwissenschaften (1)
Due to an increasing awareness of the potential hazardousness of air pollutants, new laws, rules and guidelines have recently been implemented globally. In this respect, numerous studies have addressed traffic-related exposure to particulate matter using stationary technology so far. By contrast, only few studies used the advanced technology of mobile exposure analysis. The Mobile Air Quality Study (MAQS) addresses the issue of air pollutant exposure by combining advanced high-granularity spatial-temporal analysis with vehicle-mounted, person-mounted and roadside sensors. The MAQS-platform will be used by international collaborators in order 1) to assess air pollutant exposure in relation to road structure, 2) to assess air pollutant exposure in relation to traffic density, 3) to assess air pollutant exposure in relation to weather conditions, 4) to compare exposure within vehicles between front and back seat (children) positions, and 5) to evaluate "traffic zone"- exposure in relation to non-"traffic zone"-exposure. Primarily, the MAQS-platform will focus on particulate matter. With the establishment of advanced mobile analysis tools, it is planed to extend the analysis to other pollutants including including NO2, SO2, nanoparticles, and ozone.
The Born cross sections of the e+e− → D*+D*− and e+e− → D*+D− processes are measured using e+e− collision data collected with the BESIII experiment at center-of-mass energies from 4.085 to 4.600 GeV, corresponding to an integrated luminosity of 15.7 fb−1. The results are consistent with and more precise than the previous measurements by the Belle, Babar and CLEO collaborations. The measurements are essential for understanding the nature of vector charmonium and charmonium-like states.
Investigation of the sympathetic regulation in delayed onset muscle soreness: results of an RCT
(2021)
Sports-related pain and injury is directly linked to tissue inflammation, thus involving the autonomic nervous system (ANS). In the present experimental study, we disable the sympathetic part of the ANS by applying a stellate ganglion block (SGB) in an experimental model of delayed onset muscle soreness (DOMS) of the biceps muscle. We included 45 healthy participants (female 11, male 34, age 24.16 ± 6.67 years [range 18–53], BMI 23.22 ± 2.09 kg/m2) who were equally randomized to receive either (i) an SGB prior to exercise-induced DOMS (preventive), (ii) sham intervention in addition to DOMS (control/sham), or (iii) SGB after the induction of DOMS (rehabilitative). The aim of the study was to determine whether and to what extent sympathetically maintained pain (SMP) is involved in DOMS processing. Focusing on the muscular area with the greatest eccentric load (biceps distal fifth), a significant time × group interaction on the pressure pain threshold was observed between preventive SGB and sham (p = 0.034). There was a significant effect on pain at motion (p = 0.048), with post hoc statistical difference at 48 h (preventive SGB Δ1.09 ± 0.82 cm VAS vs. sham Δ2.05 ± 1.51 cm VAS; p = 0.04). DOMS mediated an increase in venous cfDNA -as a potential molecular/inflammatory marker of DOMS- within the first 24 h after eccentric exercise (time effect p = 0.018), with a peak at 20 and 60 min. After 60 min, cfDNA levels were significantly decreased comparing preventive SGB to sham (unpaired t-test p = 0.008). At both times, 20 and 60 min, cfDNA significantly correlated with observed changes in PPT. The 20-min increase was more sensitive, as it tended toward significance at 48 h (r = 0.44; p = 0.1) and predicted the early decrease of PPT following preventive stellate blocks at 24 h (r = 0.53; p = 0.04). Our study reveals the broad impact of the ANS on DOMS and exercise-induced pain. For the first time, we have obtained insights into the sympathetic regulation of pain and inflammation following exercise overload. As this study is of a translational pilot character, further research is encouraged to confirm and specify our observations.
Diese Dissertation befasst sich mit den Auswirkungen von nicht letalen Dosen von Neonikotinoiden auf Bienen. Neonikotinoide stellen eine Klasse von Insektiziden dar, die auf den nikotinischen Acetylcholin Rezeptor wirken. In dieser Dissertation wurden die Neonikotinoide Imidacloprid, Clothianidin und Thiacloprid benutzt. Die beiden erst genannten unterliegen zum Zeitpunkt des Verfassens dieser Arbeit einem temporären Verkaufs- und Ausbringungs-Stopp. Damit sind die Ergebnisse dieser Arbeit wichtig für die Bewertung der Gefahren von Neonikotinoiden. Neonikotinoide werden im großen Maße in der Landwirtschaft als Spritzmittel und Saatgutbeize eingesetzt. Dabei können sie in Rückständen von Bienen beim Sammeln von Nektar und Pollen aufgenommen und zum Stock gebracht werden. Um einen weiten Blick auf die Auswirkungen der Stoffe zu werfen wurden deshalb Experimente an einzelnen Sammlerinnen durchgeführt, ebenso wie an Bienenvölkern, bei denen die Substanzen verfüttert wurden. Als neuronal aktive Substanzen können sie die normale Funktion des Nervensystems von Bienen beeinflussen, was Veränderungen im Verhalten hervorrufen kann. Dies zeigt sich in Veränderungen in der Bewegung, Orientierung oder auch Interaktion mit anderen Bienen. Die Wirkung am Rezeptor variiert, trotz gleichen molekularen Ziels, stark zwischen den verwendeten Neonikotinoiden. Clothianidin wurde als Agonist beschrieben, der sogar stärkere Ströme als Acetylcholin bei gleicher Konzentration hervorrufen kann. Imidacloprid dagegen wurde bereits als partieller Agonist beschrieben, der geringere Ströme über den Rezeptor auslöst. In dieser Arbeit wurde ein erster Versuch durchgeführt um Thiacloprid ebenfalls als Agonist am nikotinischen Acetylcholin Rezeptor der Biene zu beschreiben. Hierbei wurde an einer Zelle in Kultur ein geringerer Strom ausgelöst.
Bienenvölker wurden unter kontrollierten Bedingungen gehalten, bei denen je eins der Neonikotinoide Clothianidin, Imidacloprid oder Thiacloprid in das Futter gemischt wurden. Hierfür wurden Dosen gewählt, bei denen davon ausgegangen werden konnte, dass keine akute Beeinflussung der Sammlerinnen bestand. Es konnte festgestellt werden, dass chronisches Füttern mit einer Zuckerlösung mit 8,876 mg/kg Thiacloprid zu einer verringerten Sammelleistung führte. Ebenso wurde die Entwicklung der Eier stark eingeschränkt, wobei die Königin weiterhin Eier legte. Es konnten nur vereinzelte verdeckelte Brutzellen, die ein spätes Entwicklungsstadium der Bienen darstellen, gefunden werden. Damit konnte gezeigt werden, dass geringe Dosen die Larval-Entwicklung von Bienen beeinflussen, eventuell durch Einflüsse auf die Kommunikation zwischen Ammenbienen und der Brut.
Um Auswirkungen auf einzelne Tiere zu zeigen, wurden unterschiedliche Parameter im Heimflug von Bienen nach Fütterung mit je einem der Neonikotinoide analysiert. Bienen mussten sich nach der Fütterung orientieren und von einer neuen Position den Heimweg zum Stock finden. Der Heimflug wurde per Radar verfolgt und so ein Flugprofil erstellt, das aus zwei Flugphasen bestand. Diese wurden durch die Navigation nach Vektorintegration und durch Landmarken unterteilt. Aus dem Flugprofil konnte abgelesen werden, wie lange die Bienen für die Phasen des Flugs benötigten, in welchem Hauptflugwinkel sie die erste Flugphase absolvierten, in welche Richtung sie am Ende der ersten Flugphase flogen und wie gerichtet der Flug war. Auch wurde erfasst, ob die Bienen überhaupt in der Lage waren zum Stock zurückzukehren. Hier zeigte sich, dass die Fütterung mit Zuckerwasser mit 0,6 µM und 0,9 µM Imidacloprid, ebenso wie mit 0,1 mM Thiacloprid zu einer verringerten Heimkehrwahrscheinlichkeit führte. In der ersten Flugphase konnte auch gezeigt werden, dass 0,2 µM Clothianidin im Zuckerwasser zu einem schnelleren Flug führte und dass der Flugwinkel im Vergleich zur Kontrolle in Richtung der wahren Position des Stocks verschoben war. Beide Imidacloprid-Gruppen zeigten eine ähnliche, signifikante Verschiebung des Flugwinkels, ebenso konnte im Flug selbst eine häufige Änderung der Richtung festgestellt werden. In der zweiten Flugphase zeigte sich, dass Bienen, welche mit Thiacloprid behandelt wurden häufiger eine inkorrekte Heimflugrichtung wählten, was in längeren Heimflügen resultierte. Die mit Clothianidin behandelten Bienen legten eine längere Flugstrecke zurück. Bienen, welche Imidacloprid beider Konzentrationen konsumierten, zeigten einen häufigen Wechsel ihrer Flugrichtung. Damit konnten bei allen drei gewählten Neonikotinoiden Einflüsse auf spezifische Komponenten der Navigation von Bienen gefunden und Einschränkungen im Heimkehr- und Orientierungsverhalten einzelner Sammlerinnen gezeigt werden. Somit konnten die eingehenden Fragen zumindest teilweise beantwortet werden und die Datenlage zur Frage der Schädlichkeit der, auch politisch umstrittenen, Substanzen erweitert werden.
Three neonicotinoids, imidacloprid, clothianidin and thiacloprid, agonists of the nicotinic acetylcholine receptor in the central brain of insects, were applied at non-lethal doses in order to test their effects on honeybee navigation. A catch-and-release experimental design was applied in which feeder trained bees were caught when arriving at the feeder, treated with one of the neonicotinoids, and released 1.5 hours later at a remote site. The flight paths of individual bees were tracked with harmonic radar. The initial flight phase controlled by the recently acquired navigation memory (vector memory) was less compromised than the second phase that leads the animal back to the hive (homing flight). The rate of successful return was significantly lower in treated bees, the probability of a correct turn at a salient landscape structure was reduced, and less directed flights during homing flights were performed. Since the homing phase in catch-and-release experiments documents the ability of a foraging honeybee to activate a remote memory acquired during its exploratory orientation flights, we conclude that non-lethal doses of the three neonicotinoids tested either block the retrieval of exploratory navigation memory or alter this form of navigation memory. These findings are discussed in the context of the application of neonicotinoids in plant protection.
A new, two-channel instrument for simultaneous NO3 and N2O5 monitoring was used to make the first comprehensive set of nocturnal NOx measurements (NO, NO2, NO3 and N2O5) at the Taunus Observatory, a rural mountain site (Kleiner Feldberg) in South-western Germany. In May 2008, NO3 and N2O5 mixing ratios were well above the instrumental detection limit (a few ppt) on all nights of the campaign and were characterised by large variability resulting from inhomogeneously distributed sinks. The concentrations of NO3, N2O5 and NO2 were consistent with the equilibrium constant, K2, defining the rates of formation and thermal dissociation of N2O5. A steady-state lifetime analysis showed that nocturnal NOx losses were generally dominated by reaction of NO3 with volatile organic compounds in this forested region, with N2O5 uptake to aerosols of secondary importance. Analysis of a limited dataset obtained at high relative humidity indicated that the loss of N2O5 by reaction with water vapour is less efficient (> factor 3) than derived using laboratory kinetic data. The fraction of NOx present as NO3 and N2O5 reached ≈20% on some nights, with night-time losses of NOx competing with daytime losses.
A new, two-channel instrument for simultaneous NO3 and N2O5 monitoring was used to make the first comprehensive set of nocturnal NOx measurements (NO, NO2, NO3 and N2O5) at the Taunus Observatory, a rural mountain site (Kleiner Feldberg) in South-western Germany. In May 2008, NO3 and N2O5 mixing ratios were well above the instrumental detection limit (a few ppt) on all nights of the campaign and were characterised by large variability. The concentrations of NO3, N2O5 and NO2 were consistent with the equilibrium constant, K2, defining the rates of formation and thermal dissociation of N2O5. A steady-state lifetime analysis is consistent with the loss of nocturnal NOx being dominated by the reaction of NO3 with volatile organic compounds in this forested region, with N2O5 uptake to aerosols of secondary importance. Analysis of a limited dataset obtained at high relative humidity indicated that the loss of N2O5 by reaction with water vapour is less efficient (>factor 3) than derived using laboratory kinetic data. The fraction of NOx present as NO3 and N2O5 reached ~20% on some nights, with night-time losses of NOx competing with daytime losses.
Background: Chronic hepatitis C virus (HCV) infections are causally linked with metabolic comorbidities such as insulin resistance, hepatic steatosis, and dyslipidemia. However, the clinical impact of HCV eradication achieved by direct-acting antivirals (DAAs) on glucose and lipid homeostasis is still controversial. The study aimed to prospectively investigate whether antiviral therapy of HCV with DAAs alters glucose and lipid parameters. Methods: 50 patients with chronic HCV who were treated with DAAs were screened, and 49 were enrolled in the study. Biochemical and virological data, as well as noninvasive liver fibrosis parameters, were prospectively collected at baseline, at the end of treatment (EOT) and 12 and 24 weeks post-treatment. Results: 45 of 46 patients achieved sustained virologic response (SVR). The prevalence of insulin resistance (HOMA-IR) after HCV clearance was significantly lower, compared to baseline (5.3 ± 6.1 to 2.5 ± 1.9, p < 0.001), which is primarily attributable to a significant decrease of fasting insulin levels (18.9 ± 17.3 to 11.7 ± 8.7; p = 0.002). In contrast to that, HCV eradication resulted in a significant increase in cholesterol levels (total cholesterol, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein (HDL-C) levels) and Controlled Attenuated Score (CAP), although BMI did not significantly change over time (p = 0.95). Moreover, HOMA-IR correlated significantly with noninvasive liver fibrosis measurements at baseline und during follow-up (TE: r = 0.45; p = 0.003, pSWE: r = 0.35; p = 0.02, APRI: r = 0.44; p = 0.003, FIB-4: r = 0.41; p < 0.001). Conclusion: Viral eradication following DAA therapy may have beneficial effects on glucose homeostasis, whereas lipid profile seems to be worsened.
Bipolar disorder (BD) is a highly heritable neuropsychiatric disease characterized by recurrent episodes of mania and depression. BD shows substantial clinical and genetic overlap with other psychiatric disorders, in particular schizophrenia (SCZ). The genes underlying this etiological overlap remain largely unknown. A recent SCZ genome wide association study (GWAS) by the Psychiatric Genomics Consortium identified 128 independent genome-wide significant single nucleotide polymorphisms (SNPs). The present study investigated whether these SCZ-associated SNPs also contribute to BD development through the performance of association testing in a large BD GWAS dataset (9747 patients, 14278 controls). After re-imputation and correction for sample overlap, 22 of 107 investigated SCZ SNPs showed nominal association with BD. The number of shared SCZ-BD SNPs was significantly higher than expected (p = 1.46x10-8). This provides further evidence that SCZ-associated loci contribute to the development of BD. Two SNPs remained significant after Bonferroni correction. The most strongly associated SNP was located near TRANK1, which is a reported genome-wide significant risk gene for BD. Pathway analyses for all shared SCZ-BD SNPs revealed 25 nominally enriched gene-sets, which showed partial overlap in terms of the underlying genes. The enriched gene-sets included calcium- and glutamate signaling, neuropathic pain signaling in dorsal horn neurons, and calmodulin binding. The present data provide further insights into shared risk loci and disease-associated pathways for BD and SCZ. This may suggest new research directions for the treatment and prevention of these two major psychiatric disorders.
Recent studies suggest that synaptic lysophosphatidic acids (LPAs) augment glutamate-dependent cortical excitability and sensory information processing in mice and humans via presynaptic LPAR2 activation. Here, we studied the consequences of LPAR2 deletion or antagonism on various aspects of cognition using a set of behavioral and electrophysiological analyses. Hippocampal neuronal network activity was decreased in middle-aged LPAR2−/− mice, whereas hippocampal long-term potentiation (LTP) was increased suggesting cognitive advantages of LPAR2−/− mice. In line with the lower excitability, RNAseq studies revealed reduced transcription of neuronal activity markers in the dentate gyrus of the hippocampus in naïve LPAR2−/− mice, including ARC, FOS, FOSB, NR4A, NPAS4 and EGR2. LPAR2−/− mice behaved similarly to wild-type controls in maze tests of spatial or social learning and memory but showed faster and accurate responses in a 5-choice serial reaction touchscreen task requiring high attention and fast spatial discrimination. In IntelliCage learning experiments, LPAR2−/− were less active during daytime but normally active at night, and showed higher accuracy and attention to LED cues during active times. Overall, they maintained equal or superior licking success with fewer trials. Pharmacological block of the LPAR2 receptor recapitulated the LPAR2−/− phenotype, which was characterized by economic corner usage, stronger daytime resting behavior and higher proportions of correct trials. We conclude that LPAR2 stabilizes neuronal network excitability upon aging and allows for more efficient use of resting periods, better memory consolidation and better performance in tasks requiring high selective attention. Therapeutic LPAR2 antagonism may alleviate aging-associated cognitive dysfunctions.